当前位置:首页 - 行情中心 - 立方制药(003020) - 财务分析 - 现金流量表

立方制药

(003020)

  

流通市值:28.69亿  总市值:38.84亿
流通股本:1.69亿   总股本:2.28亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金833,710,494.11416,176,012.551,646,994,726.181,219,554,435.8
  收到的税费返还456,393.56,837.0318,636,426.9218,754,208.65
  收到其他与经营活动有关的现金14,385,338.7518,062,88371,794,398.3962,164,969.86
  经营活动现金流入小计848,552,226.36434,245,732.581,737,425,551.491,300,473,614.31
  购买商品、接受劳务支付的现金205,005,613.43131,639,558.11499,001,575.37383,767,579.62
  支付给职工以及为职工支付的现金116,235,082.9562,463,470.64208,698,025.06158,566,262.36
  支付的各项税费83,402,595.9943,796,070.44187,201,861.82129,451,331.11
  支付其他与经营活动有关的现金281,437,277.38132,675,797.66629,638,871.54440,664,691.96
  经营活动现金流出小计686,080,569.75370,574,896.851,524,540,333.791,112,449,865.05
  经营活动产生的现金流量净额162,471,656.6163,670,835.73212,885,217.7188,023,749.26
二、投资活动产生的现金流量:
  收回投资收到的现金474,990,000160,000,000938,789,470.8598,377,416.01
  取得投资收益收到的现金9,688,405.86627,858.4724,522,190.1223,201,455.24
  处置固定资产、无形资产和其他长期资产收回的现金净额330,237.951,779.758,004,480.761,721,995.41
  收到的其他与投资活动有关的现金---25,300
  投资活动现金流入小计485,008,643.81160,629,638.22971,316,141.68623,326,166.66
  购建固定资产、无形资产和其他长期资产支付的现金62,752,865.4730,129,805.62118,456,422.4191,122,899.62
  投资支付的现金739,990,000330,000,000911,860,000611,860,000
  投资活动现金流出小计802,742,865.47360,129,805.621,030,316,422.41702,982,899.62
  投资活动产生的现金流量净额-317,734,221.66-199,500,167.4-59,000,280.73-79,656,732.96
三、筹资活动产生的现金流量:
  吸收投资收到的现金--25,300-
  取得借款收到的现金30,000,00010,000,000--
  收到其他与筹资活动有关的现金77,855-1,140,521.750
  筹资活动现金流入小计30,077,85510,000,0001,165,821.750
  偿还债务支付的现金1,550,000---
  分配股利、利润或偿付利息支付的现金57,928,817.94406,471.11166,163,772.32125,760,565.92
  支付其他与筹资活动有关的现金12,253,072.042,516,170.4514,628,271.8619,706,198.52
  筹资活动现金流出小计71,731,889.982,922,641.56180,792,044.18145,466,764.44
  筹资活动产生的现金流量净额-41,654,034.987,077,358.44-179,626,222.43-145,466,764.44
四、汇率变动对现金及现金等价物的影响-99,521.94-79,524.7-59,152.46-23,824.49
五、现金及现金等价物净增加额-197,016,121.97-128,831,497.93-25,800,437.92-37,123,572.63
  加:期初现金及现金等价物余额413,893,621.67413,893,621.67439,694,059.59439,694,059.59
  期末现金及现金等价物余额216,877,499.7285,062,123.74413,893,621.67402,570,486.96
补充资料:
  净利润85,085,713.78-163,551,446.54-
  资产减值准备4,177,665.87-11,469,964.79-
  固定资产和投资性房地产折旧39,983,010.64-74,837,921.3-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧39,983,010.64-74,837,921.3-
  无形资产摊销4,855,791.19-9,790,058.12-
  长期待摊费用摊销1,036,579.82-2,773,038.38-
  处置固定资产、无形资产和其他长期资产的损失-49,792.43-1,677.88-
  固定资产报废损失6,641.53-652,887.92-
  公允价值变动损失-313,697.46--149,013.75-
  财务费用1,083,461.87-2,398,963.88-
  投资损失-3,040,602.85--27,718,188.08-
  递延所得税-2,251,370.45--2,872,314.75-
  其中:递延所得税资产减少-1,511,555.62--1,301,300.35-
    递延所得税负债增加-739,814.83--1,571,014.4-
  存货的减少-47,090,245.89-5,348,254.16-
  经营性应收项目的减少67,808,841.65--26,739,536.81-
  经营性应付项目的增加6,560,056.35--6,610,805.57-
  其他2,120,154.13-298,212.33-
  融资租入固定资产--1,625,611.21-
  现金的期末余额216,877,499.7-413,893,621.67-
  减:现金的期初余额413,893,621.67-439,694,059.59-
  现金及现金等价物的净增加额-197,016,121.97--25,800,437.92-
公告日期2026-08-292026-04-282026-04-282025-10-30
审计意见(境内)标准无保留意见
TOP↑